http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2143695-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d155d7cb977a834cc6abe08241eb413 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d67d8114b3f36ffa55e5ea1b6004e7ca |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate | 1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99bfa29ba4d44c430f0b7d5d960fb0f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea0f724e0b41f67627c45ce932afcef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ab0e0cd74fd612920b11f9791fef97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4942603f83b0bde732c538c529b013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab3778d314f6e635d01ae2f400853679 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9f357310f2c46cd63d9ceaa2c3c4420 |
| publicationDate | 1999-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2143695-C1 |
| titleOfInvention | Differential diagnosis method for diagnosing chronic obstructive pulmonary diseases |
| abstract | FIELD: medicine. SUBSTANCE: method involves studying broncho-alveolar lavage liquid. Mononuclear migration inhibition reaction in the presence of phytohemagglutinin (PHA) is set in addition. Mononuclear migration inhibition index is calculated from formula MII = (1- migration under PHA / migration without PHA)*100%. Oxalate contents in the broncho-alveolar lavage liquid and in urine is measured. Oxalate contents in the broncho-alveolar lavage liquid being twice or more as high as that in the urine and mononuclear MII being negative, oxalate form of chronic obstructive pulmonary disease is to be diagnosed. EFFECT: enhanced effectiveness in diagnosing oxalate form of the disease; selected pathogenetically reasonable therapy method. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2678577-C1 |
| priorityDate | 1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.